investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Systematic identification of resistance mechanisms to HER2-targeted therapies in breast cancer.
Che-Wei Chang
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Che-Wei Chang
Ontario Institute for Cancer Research
Toronto, Canada
Related projects
Susan E Erdman
GI Tract Dysbiosis and Breast Cancer
Breast
Michael C Ostrowski
Genetic Analysis of the Breast Tumor Microenvironment
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast
Shyam Sharan
Functional Analysis of Breast Cancer Susceptibility Genes in Mice
Breast
Robert I Benezra
The Role of Endothelial Progenitor Cells in Tumor Growth and Metastasis
Breast
Xiaojiang Cui
The Role of FOXC1 in Basal-Like Breast Cancer
Breast
Carol Prives
Roles and Regulation of p53
Breast
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
